Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Science at the heart of medicine Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC) Seminar Series Director: Steven U. Walkley, DVM., Ph.D. Associate Director: John J. Foxe, Ph.D. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Moving from Genes to Treatments: The Example of Familial Dysautonomia Susan A. Slaugenhaupt, Ph.D. Associate Professor of Neurology (Genetics) Center for Human Genetic Research Massachusetts General Hospital/Harvard Medical School LeFrak Auditorium, Price Center, (Room 151) 4pm, Monday, November 29, 2010 Reception to follow Biographical note: Dr. Slaugenhaupt is a principal investigator in the Center for Human Genetic Research, Associate Professor at Harvard Medical School, and Associate Geneticist in the Department of Neurology/Molecular Neurogenetics Unit at Massachusetts General Hospital. She is also Co-Director of the Genetics and Genomics Unit of the MGH Clinical Research Program. One of the programs in Dr. Slaugenhaupt’s lab is focused on understanding and treating the neurologic disorder familial dysautonomia. Her lab discovered that the disease is caused by faulty mRNA splicing and they have identified a drug to target the molecular defect. Website: http://www2.massgeneral.org/chgr/faculty_slaugenhaupt.htm Please contact: Dr. Steven Walkley ([email protected]) for information.